Form 4: Inhibrx Biosciences Director Vuori Acquires Shares
SEC Form 4 Filing
Kristiina Vuori, a director of Inhibrx Biosciences, purchased 6,667 shares of common stock at $15 per share on October 3, 2024.
Summary
- On October 3, 2024, Kristiina Vuori, a director of Inhibrx Biosciences, Inc. (INBX), acquired 6,667 shares of common stock at a price of $15 per share.
- Following this transaction, Vuori directly owns 20,443 shares of Inhibrx Biosciences common stock.
Sentiment
Score: 6
Explanation: A director purchasing shares is generally a positive sign, suggesting confidence in the company's prospects, but it's a single transaction and doesn't provide a comprehensive view.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This purchase is specific to an individual director's investment decision.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 10/03/2024 | Date of transaction: Kristiina Vuori purchased shares of Inhibrx Biosciences. |
| 10/07/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.